  Management raised substantial doubt about the Company's ability tocontinue as a going concern. If the Company is unable to raisesufficient funds to repurchase the requisite amount of debenturesor restructure its obligations under its 0.00% ConvertibleSubordinated Debentures due 0000, it may be forced to seekprotection under the United States bankruptcy laws.  About DOV Pharmaceutical  Somerset, New Jersey-based DOV Pharmaceutical Inc. (PS: DOVP.PK)-- http://www.dovpharm.com/-- is a biopharmaceutical company focused on the discovery, acquisition, and development of noveldrug candidates for central nervous system disorders. TheCompany's product candidates address some of the largestpharmaceutical markets in the world including depression, pain andinsomnia.  